Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer

Clinical trial NCT02437370 · COMPLETED

Trial details

NCT number: NCT02437370
Sponsor: University of California, Davis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Recurrent Bladder Carcinoma Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter Regional Urothelial Carcinoma of the Renal Pelvis and Ureter Stage III Bladder Urothelial Carcinoma Stage III Urethral Cancer Stage IV Bladder Urothelial Carcinoma Stage IV Urethral Cancer Urethral Urothelial Carcinoma

Start date: 2015-09-01
Primary completion: 2019-08-07
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.